Research Article
Prevalence of HIV Antiretroviral Drug Resistance and Its Impacts on HIV-1 Virological Failures in Jiangsu, China: A Cross-Sectional Study
Table 2
Logistic regression analysis of factors associated with HIV-1 drug resistance.
| Factors | Variables | value | RR | 95% CI for RR | Lower | Upper |
| Gender | Male | | 1 | | | Female | 0.019 | 0.362 | 0.155 | 0.844 |
| WHO clinical stages | I | 0.297 | | | | II | 0.085 | 1.926 | 0.913 | 4.063 | III | 0.224 | 1.815 | 0.694 | 4.742 | IV | 0.859 | 1.125 | 0.308 | 4.102 |
| Treated duration | <1 | 0.009 | | | | 1-2 | 0.014 | 13.616 | 1.715 | 108.109 | 2-3 | 0.007 | 19.556 | 2.278 | 167.857 | >3 | 0.001 | 50.579 | 4.855 | 526.891 |
| Side effect | Yes | | 1 | | | No | 0.186 | 20576 | 0.634 | 10.468 |
| SMZ taken | Yes | | 1 | | | No | 0.123 | 3.707 | 0.700 | 19.633 |
|
|
SMZ: compound sulfamethoxazole.
|